Logo image of 3AI.DE

ALTERYX INC - CLASS A (3AI.DE) Stock Fundamental Analysis

FRA:3AI - Deutsche Boerse Ag - US02156B1035 - Common Stock - Currency: EUR

34.4  -0.5 (-1.43%)

Fundamental Rating

3

Taking everything into account, 3AI scores 3 out of 10 in our fundamental rating. 3AI was compared to 100 industry peers in the Software industry. 3AI has a bad profitability rating. Also its financial health evaluation is rather negative. 3AI shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year 3AI was profitable.
3AI had a negative operating cash flow in the past year.
In multiple years 3AI reported negative net income over the last 5 years.
Of the past 5 years 3AI 4 years had a positive operating cash flow.
3AI.DE Yearly Net Income VS EBIT VS OCF VS FCF3AI.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 -100M -200M -300M

1.2 Ratios

3AI has a worse Return On Assets (-17.43%) than 89.90% of its industry peers.
Looking at the Return On Equity, with a value of -433.88%, 3AI is doing worse than 91.92% of the companies in the same industry.
Industry RankSector Rank
ROA -17.43%
ROE -433.88%
ROIC N/A
ROA(3y)-11.12%
ROA(5y)-5.36%
ROE(3y)-77.7%
ROE(5y)-43.49%
ROIC(3y)N/A
ROIC(5y)N/A
3AI.DE Yearly ROA, ROE, ROIC3AI.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -50 -100 -150

1.3 Margins

3AI has a Gross Margin of 85.95%. This is amongst the best in the industry. 3AI outperforms 80.81% of its industry peers.
In the last couple of years the Gross Margin of 3AI has remained more or less at the same level.
3AI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.95%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y0.66%
3AI.DE Yearly Profit, Operating, Gross Margins3AI.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 60 80

More info and screens

1

2. Health

2.1 Basic Checks

3AI does not have a ROIC to compare to the WACC, probably because it is not profitable.
3AI has more shares outstanding than it did 1 year ago.
3AI has a worse debt/assets ratio than last year.
3AI.DE Yearly Shares Outstanding3AI.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
3AI.DE Yearly Total Debt VS Total Assets3AI.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 500M 1B 1.5B

2.2 Solvency

3AI has an Altman-Z score of 0.67. This is a bad value and indicates that 3AI is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.67, 3AI is not doing good in the industry: 79.80% of the companies in the same industry are doing better.
3AI has a Debt/Equity ratio of 12.51. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 12.51, 3AI is doing worse than 91.92% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 12.51
Debt/FCF N/A
Altman-Z 0.67
ROIC/WACCN/A
WACC9.4%
3AI.DE Yearly LT Debt VS Equity VS FCF3AI.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 1.33 indicates that 3AI should not have too much problems paying its short term obligations.
3AI's Current ratio of 1.33 is in line compared to the rest of the industry. 3AI outperforms 44.44% of its industry peers.
A Quick Ratio of 1.33 indicates that 3AI should not have too much problems paying its short term obligations.
3AI has a Quick ratio (1.33) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 1.33
3AI.DE Yearly Current Assets VS Current Liabilites3AI.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 177.03% over the past year.
The Revenue has grown by 26.40% in the past year. This is a very strong growth!
3AI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.41% yearly.
EPS 1Y (TTM)177.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%680%
Revenue 1Y (TTM)26.4%
Revenue growth 3Y26.97%
Revenue growth 5Y45.41%
Sales Q2Q%7.56%

3.2 Future

Based on estimates for the next years, 3AI will show a very strong growth in Earnings Per Share. The EPS will grow by 105.48% on average per year.
Based on estimates for the next years, 3AI will show a quite strong growth in Revenue. The Revenue will grow by 17.75% on average per year.
EPS Next Y1046.25%
EPS Next 2Y324.56%
EPS Next 3Y184.31%
EPS Next 5Y105.48%
Revenue Next Year12.14%
Revenue Next 2Y12.16%
Revenue Next 3Y13.23%
Revenue Next 5Y17.75%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
3AI.DE Yearly Revenue VS Estimates3AI.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
3AI.DE Yearly EPS VS Estimates3AI.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 66.15, the valuation of 3AI can be described as expensive.
3AI's Price/Earnings is on the same level as the industry average.
The average S&P500 Price/Earnings ratio is at 27.35. 3AI is valued rather expensively when compared to this.
The Price/Forward Earnings ratio is 33.35, which means the current valuation is very expensive for 3AI.
The rest of the industry has a similar Price/Forward Earnings ratio as 3AI.
When comparing the Price/Forward Earnings ratio of 3AI to the average of the S&P500 Index (37.54), we can say 3AI is valued inline with the index average.
Industry RankSector Rank
PE 66.15
Fwd PE 33.35
3AI.DE Price Earnings VS Forward Price Earnings3AI.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
3AI.DE Per share data3AI.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

3AI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
3AI's earnings are expected to grow with 184.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.06
PEG (5Y)N/A
EPS Next 2Y324.56%
EPS Next 3Y184.31%

More info and screens

0

5. Dividend

5.1 Amount

3AI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALTERYX INC - CLASS A

FRA:3AI (11/24/2023, 7:00:00 PM)

34.4

-0.5 (-1.43%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.47B
Analysts73.91
Price Target44.26 (28.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)334.41%
Min EPS beat(2)45.05%
Max EPS beat(2)623.77%
EPS beat(4)4
Avg EPS beat(4)190.02%
Min EPS beat(4)28.76%
Max EPS beat(4)623.77%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.77%
Min Revenue beat(2)2.27%
Max Revenue beat(2)9.26%
Revenue beat(4)3
Avg Revenue beat(4)4.2%
Min Revenue beat(4)-1.47%
Max Revenue beat(4)9.26%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.78%
PT rev (3m)-4.79%
EPS NQ rev (1m)-1.99%
EPS NQ rev (3m)-3.32%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.08%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.03%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5%
Valuation
Industry RankSector Rank
PE 66.15
Fwd PE 33.35
P/S 2.92
P/FCF N/A
P/OCF N/A
P/B 40.08
P/tB N/A
EV/EBITDA N/A
EPS(TTM)0.52
EY1.51%
EPS(NY)1.03
Fwd EY3%
FCF(TTM)-0.53
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS11.79
BVpS0.86
TBVpS-4.89
PEG (NY)0.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -17.43%
ROE -433.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.95%
FCFM N/A
ROA(3y)-11.12%
ROA(5y)-5.36%
ROE(3y)-77.7%
ROE(5y)-43.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.65%
GM growth 5Y0.66%
F-Score5
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 12.51
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 3.93%
Cap/Sales 0.16%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.33
Quick Ratio 1.33
Altman-Z 0.67
F-Score5
WACC9.4%
ROIC/WACCN/A
Cap/Depr(3y)160.4%
Cap/Depr(5y)158.92%
Cap/Sales(3y)4.73%
Cap/Sales(5y)3.92%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%680%
EPS Next Y1046.25%
EPS Next 2Y324.56%
EPS Next 3Y184.31%
EPS Next 5Y105.48%
Revenue 1Y (TTM)26.4%
Revenue growth 3Y26.97%
Revenue growth 5Y45.41%
Sales Q2Q%7.56%
Revenue Next Year12.14%
Revenue Next 2Y12.16%
Revenue Next 3Y13.23%
Revenue Next 5Y17.75%
EBIT growth 1Y15.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year5105.21%
EBIT Next 3Y389.69%
EBIT Next 5YN/A
FCF growth 1Y-183.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-152.07%
OCF growth 3YN/A
OCF growth 5YN/A